论文部分内容阅读
脂肪肝病人多伴有血脂升高、血液流变学异常,血脂康具有降血脂,改善微循环的药理作用,因此我们应用血脂康治疗40例脂肪肝病人并进行了疗效观察及血液流变学分析。 一、资料与方法 1.病例选择:对48例经B超诊断为脂肪肝病人进行血脂测定,其中40例血脂增高为入选病例,其中男26例,女14例。年龄30～74岁,平均49岁。 2.方法:①所有病例均予血脂康0.6g,每日二次,治疗三个月。其用药前、中、后各查一次血脂、血液流变性及B超。用药全程禁用其它影响血脂及护肝药物。②脂肪肝超声诊断标准:肝脏大小可正常或略增大,边缘变钝,肝内回声前部密集增
Fatty liver patients often accompanied by elevated blood lipids, abnormal blood rheology, Xuezhikang with lipid-lowering, improve the pharmacological effects of microcirculation, so we use Xuezhikang treatment of 40 patients with fatty liver and the efficacy of observation and hemorheology analysis. Data and Methods 1. Case Selection: Forty-eight patients with fatty liver diagnosed by B-ultrasonography were enrolled in the study. Among them, 40 cases of elevated lipids were selected as cases, including 26 males and 14 females. Age 30 ~ 74 years old, average 49 years old. 2. Methods: ① All cases were Xuezhikang 0.6g, twice daily, for three months. The drug before, during and after check each lipids, hemorheology and B ultrasound. Drugs to disable other effects of blood lipid and liver protection drugs. ② Fatty liver ultrasound diagnostic criteria: the size of the liver may be normal or slightly increased, blunt edges, the front of the liver echo intensive